Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19
Stock Information for Altimmune Inc.
Loading
Please wait while we load your information from QuoteMedia.